1. Home
  2. WORX vs CNSP Comparison

WORX vs CNSP Comparison

Compare WORX & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCWorx Corp.

WORX

SCWorx Corp.

HOLD

Current Price

$0.24

Market Cap

4.3M

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$6.04

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WORX
CNSP
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WORX
CNSP
Price
$0.24
$6.04
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
11.5M
73.0K
Earning Date
11-12-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,784,479.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$4.93
52 Week High
$1.84
$114.00

Technical Indicators

Market Signals
Indicator
WORX
CNSP
Relative Strength Index (RSI) 66.99 45.58
Support Level $0.18 $5.75
Resistance Level $0.19 $7.51
Average True Range (ATR) 0.02 0.72
MACD 0.01 0.09
Stochastic Oscillator 53.31 22.58

Price Performance

Historical Comparison
WORX
CNSP

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: